Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 1 | 0 | €5.67 | €8.50 | 49.912% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| Innoviva Inc. | 6 | 0 | 2 | 0 | €17.20 | €30.00 | 74.419% |
| Centene Corp. | 23 | 0 | 6 | 0 | €71.53 | €82.28 | 15.035% |
| GSK plc ADR | 6 | 0 | 0 | 0 | €36.00 | €49.33 | 37.020% |
| Humana Inc. | 24 | 0 | 2 | 0 | €333.10 | €381.80 | 14.620% |
| LivaNova plc | 12 | 0 | 2 | 0 | €45.00 | €66.49 | 47.760% |
| Icu Medical Inc. | 4 | 0 | 0 | 0 | €116.00 | €125.58 | 8.261% |
| Evolus Inc | 11 | 0 | 2 | 0 | €12.60 | €22.65 | 79.792% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €97.07 | €100.00 | 3.018% |
| Globus Medical A | 1 | 0 | 0 | 0 | €64.00 | - | - |
| Stryker Corp. | 32 | 0 | 7 | 0 | €303.80 | €340.00 | 11.915% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €89.50 | - | - |
| Corcept Therapeutics Inc. | 17 | 0 | 2 | 0 | €35.19 | €37.08 | 5.365% |
| Geron Corp. | 17 | 0 | 1 | 0 | €4.20 | €5.56 | 32.280% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €14.07 | - | - |
| Chemed Corp. | 6 | 0 | 0 | 0 | €530.00 | €600.54 | 13.308% |
| arGEN X BV | 1 | 0 | 0 | 0 | €458.50 | €470.00 | 2.508% |
| Bio-Techne Corp. | 10 | 0 | 0 | 0 | €76.00 | €75.94 | -0.084% |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | €214.30 | €248.57 | 15.992% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €169.65 | - | - |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.31 | €2.78 | 112.565% |
| Exelixis Inc. | 20 | 0 | 3 | 0 | €22.13 | €26.01 | 17.516% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €19.76 | €20.00 | 1.215% |